Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues:
Total revenues	$ 3,797	$ (40,629)	$ 66,754	$ 1,191,830
Operating expenses:
Cost of revenue	22	27,921	1,929	118,070
Research and development	171,860	115,082	329,503	205,309
Selling, general and administrative	47,101	41,590	93,879	79,845
Total operating expenses	218,983	184,593	425,311	403,224
(Loss) income from operations	(215,186)	(225,222)	(358,557)	788,606
Other income (expense):
Change in fair value of equity investments	(5,086)	(11,390)	(18,189)	(106,429)
Interest income	23,016	2,200	44,323	2,588
Other (expense) income, net	(367)	691	(8,388)	3,421
Total other income (expense)	17,563	(8,499)	17,746	(100,420)
(Loss) income before benefit from (provision for) income taxes	(197,623)	(233,721)	(340,811)	688,186
Benefit from (provision for) income taxes	2,848	157,228	5,080	(246,058)
Net (loss) income	(194,775)	(76,493)	(335,731)	442,128
Net loss attributable to noncontrolling interest	0	0	(56)	0
Net (loss) income attributable to Vir	$ (194,775)	$ (76,493)	$ (335,675)	$ 442,128
Net (loss) income per share, basic (in USD per share)	$ (1.45)	$ (0.58)	$ (2.51)	$ 3.34
Net (loss) income per share, diluted (in USD per share)	$ (1.45)	$ (0.58)	$ (2.51)	$ 3.28
Weighted-average shares outstanding, basic (in shares)	134,059,079	132,450,018	133,807,357	132,326,244
Weighted-average share outstanding, diluted	134,059,079	132,450,018	133,807,357	134,643,840
Collaboration revenue
Revenues:
Total revenues	$ (13,779)	$ (54,941)	$ 32,795	$ 1,174,715
Contract revenue
Revenues:
Total revenues	1,057	12,254	1,195	12,536
Grant revenue
Revenues:
Total revenues	$ 16,519	$ 2,058	$ 32,764	$ 4,579